← Back to Search

SKI-O-703 100 mg for Rheumatoid Arthritis

Phase 2
Waitlist Available
Research Sponsored by Oscotec Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and weeks 2, 4 8 and 12
Awards & highlights

Study Summary

This study will evaluate the safety and efficacy of SKI-O-703 compared with placebo, in patients with active rheumatoid arthritis (RA) who have had an inadequate response to conventional synthetic disease-modifying agents. Patients will be randomly assigned to one of 4 groups and will receive one of three doses of SKI-O-703 or placebo, administered orally twice daily for 12 weeks.

Eligible Conditions
  • Rheumatoid Arthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and weeks 2, 4 8 and 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and weeks 2, 4 8 and 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in disease activity score
Secondary outcome measures
Health Assessment Questionnaire-Disability Index (HAQ-DI) score
Incidence of Adverse Events (AEs)
Incidence of Serious Adverse Events (SAEs)
+3 more

Trial Design

4Treatment groups
Experimental Treatment
Placebo Group
Group I: SKI-O-703 400 mgExperimental Treatment1 Intervention
Group II: SKI-O-703 200 mgExperimental Treatment1 Intervention
Group III: SKI-O-703 100 mgExperimental Treatment1 Intervention
Group IV: PlaceboPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SKI-O-703
2019
Completed Phase 2
~70

Find a Location

Who is running the clinical trial?

Oscotec Inc.Lead Sponsor
7 Previous Clinical Trials
264 Total Patients Enrolled
1 Trials studying Rheumatoid Arthritis
48 Patients Enrolled for Rheumatoid Arthritis
~24 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top